Search results for "severity"

showing 10 items of 1287 documents

Esophageal Motility Changes after Thyroidectomy; Possible Associations with Postoperative Voice and Swallowing Disorders: Preliminary Results

2013

Objective Swallowing and voice impairment are common after thyroidectomy. We evaluated short-term functional changes in esophageal motility in a series of patients who had undergone total thyroidectomy. Several studies have investigated these symptoms by means of interviews or questionnaires. Study Design Prospective study. Setting Academic research. Materials and Methods Thirty-six consenting patients were prospectively recruited. Eligibility criteria were thyroid volume ≤60 mL, benign disease, and age between 18 and 65 years. Exclusion criteria were previous neck surgery, severe thyroiditis, hyperthyroidism, and pre- or postoperative vocal cord palsy. Voice impairment score, swallowing im…

AdultMalemedicine.medical_specialtyTime FactorsManometrymedicine.medical_treatmentComorbidityAudiologyRisk AssessmentSeverity of Illness IndexStatistics NonparametricCohort StudiesYoung AdultAge DistributionmedicineHumansEsophageal Motility DisordersProspective StudiesSex Distributiondysphagia thyroidectomy voice impairmentAgedVoice impairmentSettore MED/12 - GastroenterologiaVoice Disordersbusiness.industryIncidenceSwallowing DisordersThyroidectomyMiddle AgedThyroid DiseasesSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/18 - Chirurgia GeneraleSettore MED/31 - OtorinolaringoiatriaItalyOtorhinolaryngologyAnesthesiaThyroidectomyFemaleSurgeryDeglutition DisordersbusinessEsophageal motilityFollow-Up StudiesOtolaryngology–Head and Neck Surgery
researchProduct

Individual music therapy for depression: randomised controlled trial

2011

BackgroundMusic therapy has previously been found to be effective in the treatment of depression but the studies have been methodologically insufficient and lacking in clarity about the clinical model employed.AimsTo determine the efficacy of music therapy added to standard care compared with standard care only in the treatment of depression among working-age people.MethodParticipants (n= 79) with an ICD–10 diagnosis of depression were randomised to receive individual music therapy plus standard care (20 bi-weekly sessions) or standard care only, and followed up at baseline, at 3 months (after intervention) and at 6 months. Clinical measures included depression, anxiety, general functioning…

AdultMalemedicine.medical_specialtyTime FactorsMusic therapyAdolescentAnxietySeverity of Illness Indexlaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Randomized controlled triallawSeverity of illnessmedicineHumansAffective Symptoms030212 general & internal medicinePsychiatryMusic TherapyFinlandDepression (differential diagnoses)ta515Psychiatric Status Rating ScalesDepressive DisorderIntention-to-treat analysisOdds ratioMiddle Agedta3124Intention to Treat Analysis030227 psychiatryPsychiatry and Mental healthOutcome and Process Assessment Health Careta6131Quality of LifePhysical therapyPsychotherapy BriefAnxietyFemalemedicine.symptomPsychologyProgram EvaluationThe British Journal of Psychiatry
researchProduct

Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agents

2013

Abstract Background In chronic genotype 1 hepatitis C, telaprevir or boceprevir plus peginterferon and ribavirin have become the new standard of care. Aim of this study was to identify factors contributing to the decision whether to defer or treat with the current triple regimens. Methods Prospective assessment of eight parameters on 0-4-point scales by the attending physician at a German tertiary referral centre between 1st September 2011 and 31st December 2012. Results 307 patients were evaluated at least once by one of the 11 hepatologists involved; 267 patients were considered, but only 163 were recommended to receive triple therapy. Multivariate regression analysis revealed that a high…

AdultMalemedicine.medical_specialtyTime FactorsProlineDecision MakingHepacivirusPharmacologyAntiviral AgentsSeverity of Illness IndexPolyethylene GlycolsTelaprevirCohort Studieschemistry.chemical_compoundFibrosisBoceprevirInternal medicineDrug DiscoveryRibavirinGenotypemedicineHumansDecompensationProspective StudiesWatchful WaitingAgedDrug CarriersHepatologybusiness.industryRibavirinGastroenterologyInterferon-alphaPatient PreferenceHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseLogistic ModelschemistryTolerabilityMultivariate AnalysisDisease ProgressionDrug Therapy CombinationFemalebusinessOligopeptidesmedicine.drugDigestive and Liver Disease
researchProduct

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression

2009

Abstract Background There is substantial evidence that early improvement (EI) under antidepressant treatment is a clinically useful predictor of later treatment outcome in patients with major depressive disorders. The aim of this study was to test whether EI can also be used as a predictor for treatment outcome in patients with mild major, minor or subsyndromal depression, i.e. patients, who are typically treated by general practitioners. Methods Analyses were carried out using data from 223 patients of a 10-weeks randomized, placebo-controlled trial comparing the effectiveness of sertraline and cognitive-behavioural therapy (CBT) in patients with mild major, minor or subsyndromal depressio…

AdultMalemedicine.medical_specialtyTime FactorsSeverity of Illness Indexlaw.inventionRandomized controlled trialPredictive Value of TestslawSertralineSurveys and QuestionnairesInternal medicineSeverity of illnessmedicineHumansProspective StudiesPsychiatryProspective cohort studyDepression (differential diagnoses)Depressive DisorderDepressive Disorder MajorSertralineCognitive Behavioral TherapyHamilton Rating Scale for DepressionCombined Modality TherapyAntidepressive AgentsConfidence intervalPsychiatry and Mental healthClinical PsychologyTreatment OutcomePredictive value of testsFemalePsychologymedicine.drugJournal of Affective Disorders
researchProduct

Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

2006

Objectives: to evaluate the clinical efficacy and the effects on the quality of life of Iloprost, a prostacyclin analogue, used, according to a new protocol, in patients with Raynaud’s phenomenon secondary to Systemic Sclerosis. Methods: in this randomized study we treated 30 patients with Iloprost given by intravenous infusion, at progressively increasing doses (starting from 0.5 ng/Kg/min up 2 ng/Kg/min) over a period of 6 hours a day for ten days in two consecutive weeks, with repeated cycles at regular intervals of three months for 18 months. The results were compared with those obtained in 30 other patients, who had received the same drug but with different posologic schemes. Results: …

AdultMalemedicine.medical_specialtyTime FactorsVasodilator AgentsSeverity of Illness IndexDrug Administration ScheduleSclerodermalaw.inventionRheumatologyRandomized controlled trialQuality of lifelawSeverity of illnessmedicineHumansPharmacology (medical)IloprostProspective StudiesDosingInfusions IntravenousProspective cohort studySystemic Sclerosis Raynaud's phenomenon Iloprost Quality of lifeScleroderma SystemicDose-Response Relationship DrugVascular diseasebusiness.industryRaynaud DiseaseMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAnesthesiaQuality of LifeFemalebusinessIloprostmedicine.drugRheumatology
researchProduct

Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multi…

2008

Summary Background Carotid stenting is a potential alternative to carotid endarterectomy but whether this technique is as safe as surgery and whether the long-term protection against stroke is similar to that of surgery are unclear. We previously reported that in patients in the Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial, the rate of any stroke or death within 30 days after the procedure was higher with stenting than with endarterectomy. We now report the results up to 4 years. Methods In this follow-up study of a multicentre, randomised, open, assessor-blinded, non-inferiority trial, we compared outcome after stenting with outcome …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCarotid endarterectomyRisk AssessmentSeverity of Illness IndexFunctional LateralityDouble-Blind MethodRisk FactorsInternal medicineAngioplastyClinical endpointConfidence IntervalsMedicineHumansCarotid StenosisLife Tablescardiovascular diseasesLongitudinal StudiesStrokeEndarterectomyAgedProportional Hazards ModelsRetrospective StudiesEndarterectomy Carotidbusiness.industryHazard ratioAngioplastyMiddle Agedmedicine.diseaseSurgeryStrokeStenosisTreatment OutcomeCardiologyFemaleNeurology (clinical)Carotid stentingbusinessThe Lancet. Neurology
researchProduct

The costs of social anxiety disorder: The role of symptom severity and comorbidities

2013

Abstract Background Social anxiety disorder (SAD) is associated with low direct costs compared to other anxiety disorders while indirect costs tend to be high. Mental comorbidities have been identified to increase costs, but the role of symptom severity is still vague. The objective of this study was to determine the costs of SAD, and to explore the impact of symptoms and comorbidities on direct and indirect costs. Methods Baseline data, collected within the SOPHO-NET multi-centre treatment study ( N =495), were used. Costs were calculated based on health care utilization and lost productivity. Symptom severity was measured with the Liebowitz-Social-Anxiety-Scale; comorbidities were include…

AdultMalemedicine.medical_specialtyTotal costPopulationComorbidityEfficiencySeverity of Illness IndexYoung Adult03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessAbsenteeismmental disordersHealth caremedicineHumans030212 general & internal medicineSocial BehaviorPsychiatryeducationhealth care economics and organizationseducation.field_of_studybusiness.industrySocial anxietyMiddle Agedmedicine.diseaseAnxiety Disorders3. Good health030227 psychiatryPsychiatry and Mental healthClinical PsychologyEating disordersAbsenteeismAnxietyFemaleSelf Reportmedicine.symptomPsychologybusinessJournal of Affective Disorders
researchProduct

Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen

2018

OBJECTIVE Characteristics and risk factors (RFs) of invasive fungal disease (IFD) have been little studied in the setting of umbilical cord blood transplantation (UCBT). METHOD We retrospectively included 205 single-unit myeloablative UCBT recipients with a median follow-up of 64 months. RESULTS Fifty-six episodes of IFD were observed in 48 patients (23%) at a median time of 123 days after stem cell infusion. Invasive mold disease (IMD) occurred in 42 cases, 38 of them (90%) caused by invasive aspergillosis whereas invasive yeast disease (IYD) occurred in 14 cases, most of them due to candidemia (n = 12, 86%). The 5-year cumulative incidence of IFD, IMDs, and IYDs was 24% 19%, and 7%, respe…

AdultMalemedicine.medical_specialtyTransplantation ConditioningMultivariate analysisAdolescentGraft vs Host DiseaseDiseaseAspergillosisSeverity of Illness IndexGastroenterologyYoung Adult03 medical and health sciences0302 clinical medicineAnti-Infective AgentsRisk FactorsCause of DeathInternal medicinemedicineHumansPublic Health SurveillanceCumulative incidenceRetrospective Studiesbusiness.industryUmbilical Cord Blood TransplantationIncidenceHematologyGeneral MedicineMiddle Agedmedicine.diseasePatient Outcome AssessmentGraft-versus-host diseaseMycoses030220 oncology & carcinogenesisFemaleCord Blood Stem Cell TransplantationStem cellComplicationbusiness030215 immunologyEuropean Journal of Haematology
researchProduct

Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study.

2011

The aim of this study was to verify the efficacy and the safety of transtympanic dexamethasone to treat sudden sensorineural hearing loss as first and single drug method. Considering ethical implication of performing a mininvasive procedure on middle ear, we matched such proposed treatment with systemic prednisone administration that represents the widest adopted protocol. Randomized prospective study was conducted. The inclusion criterion was a sudden sensorineural hearing loss of at least 30 dB across three contiguous frequencies over a period of 24 h. Group A received transtympanic steroid injections; Group B received oral administration of steroids. 25 patients were treated with transty…

AdultMalemedicine.medical_specialtyTympanic MembraneHearing Loss SensorineuralAdministration OralInjections IntralesionalRisk AssessmentSeverity of Illness IndexDexamethasoneDrug Administration ScheduleAudiometryOral administrationPrednisoneSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyDexamethasoneAgedAnalysis of Variancemedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryGeneral MedicineHearing Loss SuddenMiddle AgedSurgeryCochlea Deafness Round window Sudden sensorineural hearing loss Steroid TranstympanicTreatment OutcomeOtorhinolaryngologyOtorhinolaryngologyFemaleNeurosurgeryAudiometrybusinessmedicine.drugFollow-Up Studies
researchProduct

Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpat…

2007

Abstract: Purpose: We evaluated the prevalence and estimated the incidence and risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy. Materials and Methods: From January to June 2006 patients from 28 Italian urological centers who were between 25 and 50 years old with symptoms of chronic prostatitis/chronic pelvic pain syndrome were consecutively enrolled in this prospective epidemiological case-control study. A total of 152 subjects of similar age, race and area of origin who were investigated for infertile couples but were otherwise healthy served as controls. All subjects provided a medical history and underwent different symptom sco…

AdultMalemedicine.medical_specialtyUrologyProstatitisPelvic PainHospitals SpecialSeverity of Illness IndexSettore MED/24 - UrologiaChronic prostatitis/chronic pelvic pain syndromeRisk Factorsprostate prostatitis quality of life pain life styleInternal medicineSeverity of illnessAmbulatory CarePrevalencemedicineHumansMedical historyRisk factorbusiness.industryIncidenceIncidence (epidemiology)Pelvic painMiddle AgedPrognosismedicine.diseaseProstatitisSurgeryChronic bacterial prostatitisItalyCase-Control StudiesChronic DiseaseQuality of Lifemedicine.symptombusinessJournal of Urology
researchProduct